CytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th

Cite

APA MLA Chicago

CytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th. (2026, September 15). Toronto Star. https://www.thestar.com/globenewswire/cytodyn-inc-to-present-at-the-life-sciences-investor-forum-on-september-17th/article_5a9c2c68-240a-5228-8e7e-e3badba56b5f.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Toronto Star · collected 2026-09-15 · by GlobeNewswire, Inc.

Quick Summary

CytoDyn Inc., an oncology company focused on developing leronlimab for various cancer treatments, will have its Chief Financial Officer, Robert E. Hoffman, give a live presentation at the Life Sciences Investor Forum on September 17th, 2026. The event is hosted by VirtualInvestorConferences.com and aims to provide updates on the company's progress with leronlimab, which targets the CCR5 receptor for potential use in metastatic colorectal cancer and triple-negative breast cancer.

Written by AI on 2026-09-15, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

CytoDyn Inc., a clinical-stage oncology company based in Vancouver, Wash., announced that its Chief Financial Officer, Robert E. Hoffman, will present at the Life Sciences Investor Forum on September 17, 2026. The forum is hosted by VirtualInvestorConferences.com and aims to provide updates on leronlimab, a first-in-class humanized monoclonal antibody that targets the CCR5 receptor with potential therapeutic benefits for conditions such as metastatic colorectal cancer (mCRC) and triple-negative breast cancer (TNBC). This presentation is expected to offer investors an update on the company's progress in developing these treatments.

Written for “CytoDyn Presentation Schedule” on 2026-10-31, grounded in this article and the 0 other(s) covering the same event.

Story

📰 CytoDyn Presentation Schedule

Health · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 0% of its claims. Each row says how that neighbour differs.

Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing Different event

Toronto Star

Hedges 0 of 2 claims Outlet record 64/100

“Article A announces an upcoming presentation, while Article B reports on the availability of on-demand viewing for presentations that have already occurred, indicating a difference in timing and content focus.”

How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted

sentences that state something as happening or true

Uncertain

0 of 1 hedged ("reportedly", "may", "according to")

Leaning

not political

takes no side on a contested political question

Publisher signals

64/100

Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.

Outlets on this story

Health

Same framing elsewhere

articles that frame the event the way this one does

Analyzed 2026-09-15 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability

Source leaning vs. consistency

Publisher

Toronto Star · 10757 article(s) · 28 correction(s) detected

Running correction rate · 28 correction(s)

2026-10-31

Inmate's escape is just the latest problem for Tennessee's troubled prison system

2026-10-26

Correction

2026-10-24

Correction

2026-10-22

News Clarification for Oct. 22

2026-10-21

No. 6 Hoosiers try to for rare rebound at Michigan after turning the page on 22-game winning streak

2026-10-19

Driver’s License Suspensions for Court Debt Draw Scrutiny

2026-10-16

Amputations and cancer treatment delays: Lawmakers hear testimony on Mississippi prison healthcare

2026-10-16

UPDATE: Golconda Gold Releases Q3 2026 Production Update at Galaxy

2026-10-08

News Clarification for Oct. 8

2026-10-07

Correction

2026-10-05

Entertainment Correction for Oct. 5

2026-10-03

Tennessee's prisons chief is resigning after failed execution of Christa Pike

2026-09-28

Organizations call for Action to End the Deaths of Indigenous People in Custody

2026-09-27

Police memorial recognizes six officers killed in the line of duty in 2026

2026-09-27

UPDATE: WSP to host Power & Energy-focused investor event virtually only

2026-09-26

News Clarification for Sept. 27

2026-09-26

Former federal public servant seeks better pensions for injured workers

2026-09-25

News Corrections for Sept. 25

2026-09-25

She has not been charged. But the Project South allegations have branded her with a 'scarlet letter'

2026-09-24

Correction

2026-09-23

MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

2026-09-22

Costa Rican man complained of lack of care for diabetes before his death in ICE custody, family says

2026-09-22

Judges' grilling of accused men leads to sex assault and dangerous driving cases being overturned

2026-09-20

Jura Energy Corporation Provides Clarification Regarding Media Reports Concerning Its Petroleum Rights in Pakistan

2026-09-19

New details emerge about Toronto's guns-for-hire and the 'crash-out mission" that sparked the Project South investigation

2026-09-17

UPDATE: Osisko Critical Minerals Corporation Announces C$100 Million Private Placement of Special Warrants

2026-09-17

Alabama set to execute man for pawn shop killings months after his nitrogen gas execution blocked

2026-09-04

Orca Corrects Q3 Quarterly Dividend Announcement

Who wrote this

No reporter is named on this article, beyond the feed's “GlobeNewswire, Inc.”.

Topics

CYDY CytoDyn CytoDyn Inc. VANCOUVER Wash.

Subjects

CYDY ORG · 1× Company ORG · 1× CytoDyn ORG · 1× CytoDyn Inc. ORG · 1× Robert E. Hoffman PERSON · 1× VANCOUVER GPE · 1× Wash. GPE · 1×

Narrative

CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic colorectal cancer (mCRC) and triple-negative breast cancer (TNBC), today announced that Robert E. Hoffman, Chief Financial Officer, will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026.

framing: assertive · carried by 1 article(s) · first seen 2026-09-15

🔮 CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic colorectal cancer (mCRC) and triple-negative breast cancer (TNBC), today announced that Robert E. Hoffman, Chief Financial Officer, will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026.

2026-09-15 · Toronto Star

CytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th · assertive framing

Claims (1 extracted, 0 hedged)

Hoffman → advance → September

💬Give feedback

🕘History 🎫Support

Terms · Privacy · beta v2.0.0

Articles to 31 Oct 2026